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Small patella syndrome (SPS) is an autosomal-dominant skeletal dysplasia characterized by patellar aplasia or
hypoplasia and by anomalies of the pelvis and feet, including disrupted ossiﬁcation of the ischia and inferior pubic
rami. We identiﬁed an SPS critical region of 5.6 cM on chromosome 17q22 by haplotype analysis. Putative loss-
of-function mutations were found in a positional gene encoding T-box protein 4 (TBX4) in six families with SPS.
TBX4 encodes a transcription factor with a strongly conserved DNA-binding T-box domain that is known to play
a crucial role in lower limb development in chickens and mice. The present identiﬁcation of heterozygous TBX4
mutations in SPS patients, together with the similar skeletal phenotype of animals lacking Tbx4, establish the
importance of TBX4 in the developmental pathways of the lower limbs and the pelvis in humans.
Small patella syndrome (SPS [MIM 147891]), also re-
ferred to as “Scott-Taor syndrome,” “ischio-pubic-
patellar syndrome,” “coxo-podo patellar syndrome,” or
“ischiopatellar dysplasia,” is a rare autosomal-dominant
disorder affecting skeletal structures of the lower limb
and the pelvis (Scott and Taor 1979; Vaneˇk 1981;Morin
et al. 1985; Dellestable et al. 1996; Poznanski 1997).
Essential features for the clinical diagnosis of SPS are
patellar aplasia or hypoplasia, associated with absent,
delayed, or irregular ossiﬁcation of the ischiopubic junc-
tions and/or the infra-acetabular axe-cut notches (ﬁg.
1A, 1B, and 1C) (Bongers et al. 2001). In addition, femur
and foot anomalies—including a wide space between the
ﬁrst and second toes, short fourth and ﬁfth rays of the
feet (ﬁg. 1D), and pes planus—may accompany SPS.
Craniofacial dysmorphisms have been described in re-
ports of four sporadic individuals with SPS and one fa-
milial case of SPS including micrognathia and/or cleft
palate (Sandhaus 1987; Kozlowski and Nelson 1995;
Azouz and Kozlowski 1997; Habboub and Thneibet
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1997; Bongers et al. 2001). Ofﬁah et al. (2002) proposed
that “ischio-pubic-patellar syndrome” and SPS should
be distinguished clinically, because the former condition
presents a more severe skeletal phenotype and facial fea-
tures that are not seen in SPS. SPS is clearly clinically
different from autosomal-dominant familial patella
aplasia hypoplasia (PTLAH [MIM 168860]) (Bernhang
and Levine 1973; Mangino et al. 1999). In PTLAH,
congenital aplasia or hypoplasia of the patellae are the
only clinical features. PTLAH is genetically heteroge-
neous with one locus mapped to an ∼12-cM region on
chromosome 17q22 (Mangino et al. 1999; Bongers et
al. 2002). Elsewhere, we found possible linkage of SPS
with this PTLAH locus on chromosome 17q22 in two
SPS families, suggesting that one single gene may be
involved in both disorders (families A and B in ﬁgs. 2
and 3A) (Bongers et al. 2001). Recently, patellar and
pelvic anomalies similar to those of SPS and facial fea-
tures as micrognathia/retrognathia and high or cleft pal-
ate were recognized in individuals with surviving cam-
pomelic dysplasia (MIM 114290) caused by mutations
in the SOX9 gene, located at chromosome 17q24.3
(Mansour et al. 2002). Here, we demonstrate that mu-
tations in the TBX4 gene underlie SPS.
After informed consent and approval were obtained
from the human research ethics committees of the cor-
responding institutions, blood samples were obtained
from 15 patients who were part of ﬁve families with
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Figure 1 Characteristic features of the pelvis and the lower limb in individuals with SPS. A, Radiograph of the pelvis of family A’s proband
at the age of 12 years and 11 mo, showing bilaterally absent ossiﬁcation of the ischiopubic junction (unblackened arrows), infra-acetabular
axe-cut notches (blackened arrows), and elongated femoral necks. B, Radiograph of the pelvis of family C’s proband at the age of 19 years
and 7 mo. Note that the irregular ossiﬁcation of the ischiopubic junction (unblackened arrows) and infra-acetabular axe-cut notches (blackened
arrows) are less severe, as compared to the pelvic anomalies seen in the proband of family A. C, Radiograph of the knee of family C’s proband
at the age of 19 years and 7 mo, demonstrating a small patella. D, Feet of an affected male from family C at age 14 years and 8 mo, showing
short fourth and ﬁfth rays and an increased space between the ﬁrst and second toes. (Radiograph A is reproduced from the work of Bongers
et al. [2001] with permission from the BMJ Publishing Group.)
SPS, comprising two Dutch families reported elsewhere
(families A and B) (Bongers et al. 2001), one newly iden-
tiﬁed Dutch family (family C), one Belgian family (family
D) (Bongers et al. 2001), and one Czech family (family
F) (Vaneˇk 1981); from 2 sporadic Swiss patients (families
E and G) (Burckhardt 1988) (ﬁg. 2 [family G not
shown]); and from unaffected family members. The pro-
band of the newly identiﬁed Dutch family (pedigree C
in ﬁg. 2), age 29 years at the time of examination, was
referred because of dislocation of the patellae and fa-
milial occurrence of knee complaints. At physical ex-
amination, small patellae, an increased space between
the ﬁrst and second toes, and short fourth and ﬁfth rays
were found bilaterally. She had no facial dysmorphisms.
Radiographic examination of her knees conﬁrmed pa-
tellar hypoplasia, and radiographs of the pelvis showed
irregular ossiﬁcation of the ischio-pubic junction. Phys-
ical and radiographic examination of her affected family
members demonstrated small patellae associated with
pelvic and feet anomalies characteristic of SPS in all cases
(ﬁgs. 1B–1D and 3C). All patients included in this study
had the classical SPS phenotype and fulﬁlled the essential
diagnostic criteria for SPS, comprised of patellar and
characteristic pelvic anomalies (Bongers et al. 2001). The
phenotype of the individuals with SPS in this study
ranged from small patellae, associated with irregular os-
siﬁcation of the ischiopubic junctions or infra-acetabular
axe-cut notches, to absent patellae, severe pelvic and
Reports 1241
Figure 2 Pedigrees of six unrelated kindreds with SPS. Blackened symbols denote individuals with SPS, and unblackened symbols denote
unaffected individuals. TBX4 mutation analysis was performed in all individuals indicated by an asterisk (*). The proband of the newly identiﬁed
Dutch family is indicated by an arrow.
femur anomalies, and more obvious foot anomalies. The
skeletal ﬁndings varied both within and between SPS
families, except for one family (C), in which all affected
individuals had patellar hypoplasia and only minor skel-
etal anomalies of the pelvis. A distinctive facial appear-
ance, including a high nasal bridge, micrognathia, and
a high-arched palate were found in one female patient
with SPS (family D) (Bongers et al. 2001). None of the
other patients showed facial dysmorphisms. Extensive
clinical details and photographs of SPS families A, B,
and D-G have been published elsewhere (Vaneˇk 1981;
Burckhardt 1988; Bongers et al. 2001). Control DNA
samples were obtained from 50 anonymous, unrelated
Dutch individuals. Genomic DNA was extracted from
peripheral lymphocytes by use of standard techniques
(Miller et al. 1988).
Previous studies in families A and B showed possible
linkage of SPS with a locus on chromosome 17q22 (ﬁg.
3A) (Bongers et al. 2001). The SOX9 gene is located in
this wider SPS linkage interval (data not shown). To
investigate whether SOX9 mutations could be respon-
sible for SPS, we ﬁrst performed sequence analysis of
the SOX9 gene (exons 1–3). No pathogenic SOX9 ab-
errations were found in these two families with SPS (data
not shown; primers and PCR conditions are available
on request).
Subsequently, two additional SPS families became
available for molecular investigations. We directed our
study to ﬁnd evidence for linkage of SPS with the else-
where reported candidate locus on chromosome 17q22,
in a new family (family C) and in a previously described
family (family F) (Vaneˇk 1981). Manual genotyping of
microsatellite markers from chromosome 17q22 was
performed as described elsewhere (Kremer et al. 1994).
Haplotype analysis demonstrated linkage of SPS with
the chromosome 17q22 disease locus in both families
with SPS (families C and F in ﬁg. 3A). We reﬁned the
18.8-cM candidate-gene interval to a critical region of
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Figure 3 Summary of the linkage analysis and identiﬁcation of positional candidate genes. A, Linkage analysis of four families with SPS
and one family with PTLAH. Microsatellite markers (below the line) span an interval of 24.8 cM at chromosome 17q22. The SPS critical region
(D17S957 and D17S1874) is boxed. Linkage analysis of families A and B and the clinical phenotype of families A, B, and F were described
elsewhere (Vaneˇk 1981; Bongers et al. 2001). Previous linkage studies revealed a PTLAH candidate region at chromosome 17q22 (Mangino et
al. 1999). B, Localization and schematic genomic structure of candidate genes TBX2 (exons 1–7) and TBX4 (exons 1–8) (not drawn to scale)
(UCSC Genome Bioinformatics).
5.6 cM between microsatellite marker D17S957, cen-
tromerically, and D17S1874, telomerically, with a 2.2-
cM overlap with the PTLAH candidate region (ﬁg. 3A).
The SOX9 gene is located 6Mb distal from the telomeric
ﬂanking marker, D17S1874, of this critical interval.
Inspection of genes in the SPS critical region revealed
the TBX2 and TBX4 genes as positional candidates (ﬁg.
3A and 3B). TBX2 and TBX4 belong to the T-box gene
family, encoding transcription factors characterized by
a strongly conserved DNA-binding motif (T-box do-
main) (Yi et al. 2000). Tbx2 is involved in forelimb and
hindlimb development and in the speciﬁcation of pos-
terior digit identity in chickens (Gibson-Brown et al.
1998; Suzuki et al. 2004). Studies in mice and chickens
have revealed a crucial role for Tbx4 in the development
of the lower limbs (Rodriguez-Esteban et al. 1999; Nai-
che and Papaioannou 2003; Takeuchi et al. 2003). In
chickens, it has been shown that misexpression of dom-
inant-negative Tbx4 results in legless phenotypes and in
a deformed and hypoplastic pelvis, including absent pu-
bis (Takeuchi et al. 2003). In Tbx4 null mice, the initial
patterning of the hindlimb bud appears normal, but fur-
ther hindlimb development and outgrowth does not oc-
cur (Naiche and Papaioannou 2003). TheseTbx4 animal
models clearly resemble the phenotype of individuals
with SPS. On the basis of these ﬁndings, we hypothesized
that mutations in the human homologue of Tbx4 result
in SPS. We sequenced TBX4 (exons 1–8) in the four
families mapping to 17q22, in one familial case, and in
the two unrelated sporadic individuals with SPS (primers
and PCR conditions are available on request). We iden-
tiﬁed six different heterozygous mutations in the TBX4
gene in ﬁve families and in one sporadic individual with
SPS (ﬁg. 4A, 4D). These include one nonsense, two mis-
sense, one frameshift, and one splice-site mutation and
the skipping of exon 7 of the TBX4 gene; all of these
mutations were absent in 100 control chromosomes. In
family A, a GrT transversion at nucleotide 743 that
predicts a G248V substitution in the T-box domain was
found (ﬁg. 4A). Glycine 248 is evolutionarily strongly
conserved among the T-box genes of many species (ﬁg.
4B). A structural model of the T-box predicts that sub-
stitution of the small glycine 248 by a valine will create
steric hindrance that impairs DNA binding by the neigh-
boring lysine 247 (ﬁg. 5). The G248V mutation is also
present in the affected son but not in any of the healthy
Figure 4 Molecular analysis of TBX4. A, Distribution of TBX4 gene mutations identiﬁed by sequencing. Exon boundaries are identiﬁed
by arrowheads and dotted lines, and the DNA-binding motif (T-box domain) is colored red. B, Sequence homology analysis of amino acids
248 and 531 and ﬂanking residues (NCBI BLAST). The strongly conserved amino acids of the T-box domain and the C-terminal domain are
indicated in red and green colors, respectively. The amino acids that directly contact the DNA are depicted in blue. Glycine 248 and glutamine
531 (amino acids underlined with an arrow) are strongly conserved. C, Segregation of G248V mutation in SPS pedigree A (Bongers et al. 2001).
The mutations are present in affected individuals (blackened symbols, G248V) and absent in their healthy siblings (unblackened symbols, /
). Haplotypes are deﬁned by markers D17S1604, D17S948, and D17S1874 and are encoded by numbers. Blackened bars indicate the risk
allele. Note from the mutation and haplotype analysis that the mutation has occurred de novo in the germline of one of the grandparents. D,
Segregation of exon 7 skipping in SPS pedigree F (Vaneˇk, 1981) detected by RT-PCR analysis of the fragment encompassing exons 5–8 of the
TBX4 coding region, showing an aberrant sized transcript of 172 bp in the affected individuals on agarose gel. The RT-PCR experiment was
performed in all individuals indicated by an asterisk (*).
Figure 5 Protein model of the T-box domain of TBX4, created with the help of the modelling methods described by Chinea et al. (1995)
and the resolved structure of TBX3 as template (Coll et al. 2002) (Protein Data Bank). The T-box domains of TBX3 and TBX4 show a high
degree of homology (80%) and identity (64%), which ensures a faithful prediction of the TBX4 structure. The 310 helical axis of the T-box
domains of TBX3 and TBX4 are 100% identical. The residues of the DNA are represented as a purple stick model. Protein is shown as a
ribbon model with red strands, blue helices, and green/turquoise turns and loops. The protein-DNA complex is viewed along the T-box. A, T-
box dimer binding to a DNA consensus sequence. Residue G248 (yellow) is located in the C-terminal 310 helix that interacts with the DNA in
the minor groove. B, View along the 310 helical axis of the T-box domain. The G248V mutation leads to the introduction of a hydrophobic
side chain (yellow atoms in the ball display) that is normally absent. This likely displaces water molecules that stabilize the protein-DNA
interaction through hydrogen bonding. Therefore, the G248V mutation is predicted to destabilize the TBX4-DNA interaction. Other highlighted
amino acids include F245, K247, and F249 (stick representations).
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Table 1
Sequence Anomalies and Small Deletions Found in the TBX4 Gene in SPS Families and Control Chromosomes
PRESENCE OF CHANGE
DNA CHANGEa PREDICTED EFFECT LOCATION SPS Familyb Control Chromosomesc
Likely pathogenic mutations:
184CrT Q62X Exon 1 B
IVS2-13_284del18insAGC Abnormal splicing Intron 2, Exon3 D
743GrT G248V Exon 6 A
Not detectedd Skipping exon 7 Exon 7 F
1112_1113insC Frameshift Exon 8 E
1592ArG Q531R Exon 8 C
Likely nonpathogenic polymorphisms:
17GrC G6A Exon 1 A, E, F 
104CrT A35V Exon 1 
276TrG A92A Exon 2 A, E, F
IVS3-8GrA None Intron 4 D
IVS6-18TrC None Intron 7 E
1224CrT D408D Exon 8 
1446CrT V482V Exon 8 A, B, D, F 
a Nucleotide positions are based on GenBank sequence (accession number AF188703).
b No mutation had been identiﬁed in family G.
c A plus sign () indicates that the polymorphism was found in the control chromosomes.
d The genomic basis of exon 7 skipping remains undeﬁned because the splice sites and intronic sequences ﬂanking exon
7 were normal.
relatives (ﬁg. 4C). Haplotype analysis revealed that
G248V is a de novo mutation (pedigree A in ﬁg. 4C),
which is compelling evidence for the G248V mutation
being causative for SPS in this family. In family B, a CrT
transition at nucleotide 184 was found. This mutation
is predicted to result in premature termination of the
protein (Q62X) with abolition of the T-box domain (ﬁg.
4A). This mutation occurred de novo in the germline of
one of the healthy grandparents and cosegregates with
the disease in the affected offspring. In one new family
with SPS, a 1592ArG transition in exon 8 that predicts
a missense mutation (Q531R), which cosegregates with
the disease, was identiﬁed (family C in ﬁg. 4A). Gluta-
mine 531 is strictly conserved between T-box genes of
various species (ﬁg. 4B), strongly suggesting its causative
role in the disease. In a familial case with SPS, an in-
sertion-deletion (Indel) consisting of an 18-nt deletion
(13 nt from intron 2 and 5 nt from exon 3) and an AGC
triplet insertion was found at the 3′ splice site of intron
2 (family D in ﬁg. 4A). Finally, one of the two sporadic
individuals with SPS carried an insertion 1112_1113C
in intron 8, which is predicted to result in a truncated
protein lacking 75 amino acids (family E in ﬁg. 4A).
Seven different polymorphisms were identiﬁed in seven
SPS kindreds and 100 control chromosomes (table 1).
These sequence variants were considered nonpathogenic
for SPS, since they were identiﬁed in both affected and
unaffected individuals from multiple families, in 50 con-
trol individuals, and in addition to clear pathogenic mu-
tations in SPS patients. Moreover, some of the sequence
variants are within introns or result in synonymous sub-
stitutions. In family F, in which SPS is linked to chro-
mosome 17q22 (ﬁg. 3A), and in one sporadic individual
with SPS (a member of family G), sequence analysis of
the TBX4 exons and intron-exon boundaries did not
reveal any pathogenic mutation. The possibility of a
causative deletion of the entire TBX4 gene was excluded
in family F by the identiﬁcation of heterozygous poly-
morphisms within this gene (table 1). To identify small
deletions or alternatively spliced exons, we performed
an RT-PCR of TBX4 in families F and G. Total RNA
was prepared from EBV-transformed lymphoblastoid
cell lines of families F and G by use of the Rneasy Midi
kit (Qiagen) according to the manufacturers’ conditions.
In the examined affected individuals of family F, RT-
PCR analysis of the fragment encompassing the coding
sequences of exons 5–8 showed an aberrantly sized frag-
ment of 172 bp, which was absent in the unaffected
members of this family (ﬁg. 4D). Sequencing of the latter
fragment demonstrated skipping of exon 7, resulting in
the absence of 230 nt. This leads to a shift in the reading
frame that is predicted to create a truncated protein of
307 amino acids, of which the 44 C-terminal residues
are generated from the incorrect reading frame. It is pos-
sible that a small deletion encompassing exon 7 is re-
sponsible for this abnormal TBX4 transcript, as se-
quencing of genomic DNA showed no mutations in the
splice sites and introns ﬂanking exon 7. Alternatively,
disruption of splice-enhancer sequences, buried further
into an intron of the TBX4 gene, could be causative for
the exon 7 skipping. In the sporadic individual in which
no mutation was identiﬁed, mutations in regulatory el-
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ements, introns, alternatively spliced exons, or small de-
letions (exons 1–4) within TBX4 may underlie SPS. A
more tempting explanation is that mutations in the po-
sitional candidate gene TBX2 may be responsible for the
SPS phenotype, as TBX2 expression seems to be partly
regulated by TBX4 (Naiche and Papaioannou 2003).
However, TBX2 sequence analysis revealed no patho-
genic mutations in family G (primers and PCR condi-
tions are available on request).
The precise pathogenic mechanism by which TBX4
mutations cause dominant SPS remains to be elucidated.
Haploinsufﬁciency appears to be responsible for domi-
nantly inherited SPS in at least some of the families. It
is highly likely that the Q62X and the Indel mutation
will create null alleles. Furthermore, protein modeling
predicts that the G248V mutation partially or com-
pletely disrupts DNA binding activity. Mice embryos
homozygous for the Tbx4 null allele die because of
failure of chorioallantoic fusion, whereas heterozy-
gous mutants appear to have a normal phenotype
(Naiche and Papaioannou 2003). The observation that
the human heterozygous phenotype resembles the phe-
notype of Tbx4 null mice may reﬂect differences in dos-
age sensitivity for this gene in the two species. On the
other hand, dominant-negative effects for some of the
other TBX4 mutations cannot be excluded.
The identiﬁcation of TBX4 mutations and exclusion
of SOX9 mutations in the present SPS families indicate
that SPS and surviving campomelic dysplasia are genet-
ically heterogeneous disorders. We found that TBX4
mutations account for both an SPS familial case with a
distinctive facial appearance and SPS families without
facial features. The sporadic reports on minor facial fea-
tures in individuals with skeletal features of SPS do not
allow any conclusions on the previous suggestion that
“ischio-pubic-patellar syndrome” and SPS are clinically
heterogeneous disorders (Ofﬁah et al. 2002). Intrafam-
ilial variability of patellar, pelvic, and foot anomalies
was found in all SPS families investigated in this study.
At present, evidence for a genotype-phenotype correla-
tion is lacking. Molecular analysis of additional indi-
viduals with SPS will facilitate further delineation of the
phenotypic spectrum of SPS and, ﬁnally, will contribute
to the question as to whether craniofacial anomalies are
part of the syndrome.
Our studies render a role for TBX4 in PTLAH highly
unlikely. First, the TBX4 gene is located outside the
PTLAH critical region: D17S1838 is 180 kb proximal
to TBX4. Second, we could not identify a causative
TBX4 mutation in one PTLAH family (data not shown).
However, disruption of long-range TBX4 regulatory el-
ements in PTLAH cannot be formally excluded as yet,
and we have to keep in mind that PTLAH is genetically
heterogeneous (Bongers et al. 2002).
Mutations in several T-box genes are associated with
human developmental disorders, including TBX1 with
DiGeorge syndrome, TBX22 with isolated cleft palate,
TBX3 with ulnar-mammary syndrome (UMS [MIM
181450]), and TBX5 with Holt-Oram syndrome (HOS
[MIM 142900]) (Bamshad et al. 1997; Basson et al.
1997; Packham and Brook 2003). In both UMS and
HOS, mutated TBX genes cause disrupted upper limb
development (Khan et al. 2002; Agarwal et al. 2003).
Critical stage-dependent roles of Tbx4 in lower-limb in-
itiation and outgrowth were shown by misexpression
studies of dominant-negative Tbx4 in chickens. A legless
phenotype was seen after early disruption of develop-
ment, and truncated legs and hypomorphic distal struc-
tures were seen during Tbx4 misexpression at later
developmental stages (Takeuchi et al. 2003). Pelvic
anomalies were also observed upon late misexpression
of Tbx4. The SPS phenotype suggests that human TBX4
mutations do not affect early steps in limb development,
such as limb-bud initiation, but do have a profound
effect at later stages. The late effect of TBX4 mutations
is manifested by patellar aplasia/hypoplasia and anom-
alies of the posterior structures of the foot, such as short
fourth and ﬁfth rays. Completion of ischiopubic for-
mation is another very late process in human develop-
ment that is disrupted in individuals with SPS. The type
and location of TBX4 mutations reported here are com-
parable to those of heterozygous mutations inTBX3 and
TBX5, found in UMS and HOS, respectively. UMS and
HOS are characterized by severe upper-limb anomalies,
including phocomelia, as well as several other devel-
opmental defects. The relatively mild limb phenotype
and the absence of other developmental anomalies in
SPS suggest a higher degree of redundancy for TBX4 in
comparison to TBX3 and TBX5.
Our data provide the ﬁrst evidence for a crucial role
of human TBX4 in the skeletal development of the pa-
tella, pelvis, and feet. Genes underlying syndromes char-
acterized by patellar aplasia or hypoplasia appear to be
involved in a common regulatory pathway of the pat-
terning of dorsal structures of the lower limb. Hetero-
zygous mutations in the LIM-homeodomain transcrip-
tion factor LMX1B are responsible for nail-patella
syndrome (MIM 161200). LMX1B cooperates with spe-
ciﬁc downstream PTX genes (Dreyer et al. 1998; Smidt
et al. 2000). Pitx1, in turn, encodes a transcription factor
that acts upstream of Tbx4 in hindlimb development
(Logan and Tabin 1999). Mutations in two genes from
this signaling cascade, LMX1B and TBX4, lead to ab-
normal patella formation. Therefore, it is very possible
that other genetic disorders with patellar anomalies, such
as PTLAH and Meier-Gorlin syndrome (also named
“ear, patella, short stature syndrome” [MIM 224690])
are caused by a molecular defect in the same PTX/TBX
signaling cascade.
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